Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
INSULET CORP | Director | Common Stock | 26.9K | $6.06M | $225.26 | Sep 11, 2024 | Direct |
MARAVAI LIFESCIENCES HOLDINGS, INC. | Director | Class A Common Stock | 111K | $1.19M | $10.78 | May 23, 2024 | Direct |
Editas Medicine, Inc. | Director | Common Stock | 67.7K | $382K | $5.64 | May 13, 2024 | Direct |
Editas Medicine, Inc. | Director | Stock Option (right to buy) | 25K | May 30, 2024 | Direct | ||
Bruker Cellular Analysis, Inc. | Director | Common Stock | 0 | $0.55 | Oct 2, 2023 | Direct | |
INSULET CORP | Director | Stock Option (Right to Buy) | 0 | Sep 11, 2024 | Direct |